Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl 3-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidine-1-carbonyl)-2,2-dimethyl-5,18-dioxo-7,10,13,16,22,25,28,31,34,37,40,43-dodecaoxa-4,19-diazahexatetracontan-46-oate
ID: ALA5220713
Chembl Id: CHEMBL5220713
PubChem CID: 168298884
Max Phase: Preclinical
Molecular Formula: C69H105N5O20S
Molecular Weight: 1356.68
Associated Items: